Mises à jour impartiales et pratiques en psychopharmacologie

PUBLICATIONS RÉCENTES

Guide du brexpiprazole : pharmacologie, indications, posologie et effets indésirables

Pas De Crédits
Sebastián Malleza, M.D.
Psychopharmacology Institute
Afficher plus d'informations

Quick Take Vol. 93

Pas De Crédits
Faculté: Scott R. Beach, M.D., Oliver Freudenreich, M.D., F.A.C.L.P.

Substitution des antipsychotiques en pratique clinique

Pas De Crédits
Brian Miller, M.D., Ph.D., M.P.H.
Medical College of Georgia Augusta University

Guide pratique de la fluoxétine : pharmacologie, indications, posologie et effets indésirables (Mise à jour de 2026)

Pas De Crédits
Sebastián Malleza, M.D.
Psychopharmacology Institute
Afficher plus d'informations

Cariprazine : pharmacologie, indications, recommandations posologiques et effets indésirables

0,75 CME
Ce guide traite de la cariprazine, un agoniste partiel de la dopamine approuvé par la FDA pour la schizophrénie, les épisodes maniaques aigus, le traitement adjuvant du trouble dépressif majeur et, contrairement à l’aripiprazole, la dépression bipolaire de type I. Elle entraîne peu de prise de poids à court terme ou de modification de la prolactine et figure parmi les antipsychotiques les moins sédatifs ; les contreparties sont une akathisie dose-dépendante, une efficacité se situant dans la fourchette basse de la classe dans la schizophrénie aiguë, et un métabolite dont la demi-vie est de une à trois semaines. Le guide aborde son positionnement clinique dans chaque indication, l’hypothèse D3 et les données relatives aux symptômes négatifs, les raisons pour lesquelles chaque dose nécessite plusieurs semaines avant d’être évaluée, la prise en charge de l’akathisie, les réductions de dose liées aux inhibiteurs du CYP3A4, ainsi que son utilisation pendant la grossesse, l’allaitement et chez les personnes âgées.
Sebastián Malleza, M.D.
Psychopharmacology Institute
Afficher plus d'informations

Quick Take Vol. 92

0,75 CME
L’halopéridol constitue-t-il toujours un choix pertinent dans l’agitation en situation d’urgence ? Les psychotropes autres que la clozapine et le lithium réduisent-ils le risque suicidaire ? Les agents anti-inflammatoires peuvent-ils cibler l’anhédonie dans la dépression ? L’intelligence artificielle peut-elle aider au choix d’un antidépresseur ? La buprénorphine devrait-elle être instaurée à des doses plus élevées chez les patients consommant du fentanyl ?
Faculté: Scott R. Beach, M.D., Paul Zarkowski, M.D., James Phelps, M.D., David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M.
38,28 minutes en 5 sections audio

Explorez notre vaste bibliothèque de vidéos, de résumés de recherche et d’entretiens avec des experts.

CME Information

Physicians – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medical Academy, LLC designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Download Accreditation Information (PDF)

Nursing professionals – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medical Academy, LLC designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The ANCC accepts AMA PRA Category 1 Credit(s)™ as Contact Hours, under this calculation: 1 CME = 1 Contact Hour. 

All of our content is psychopharmacology, so the pharmacology hours shown on your certificate match the credits awarded for that activity. Your certificate states them on their own line, separately from the credit designation statement.

This applies to APRN pharmacology renewal as well. Boards of nursing define pharmacology CE in their own way, so please confirm with your board that this is the documentation they expect.

Download Accreditation Information (PDF)

Physician assistants – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medical Academy, LLC designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The NCCPA accepts AMA PRA Category 1 Credit™ from providers accredited by the ACCME toward PA certification maintenance. Requirements are set by the NCCPA, so please confirm with them what your current cycle requires.

Download Accreditation Information (PDF)

Physicians outside the United States – CME Accreditation Statement

AMA PRA Category 1 Credit™ may be awarded to any physician, whether or not they are licensed in the United States. The requirements are the same.

The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMEC®s) should contact the UEMS at mutualrecognition@uems.eu.

Whether these credits count toward your own national continuing education requirement is decided by your national medical chamber or society, and the rules differ from country to country. We recommend confirming with them before relying on the credits for a licensing or recertification requirement.

Self Assessment for MOC – Accreditation Statement
  • Psychopharmacology Institute Self-Assessment Program 2026

Dates: April 1, 2026 – April 1, 2029

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2026 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

  • Psychopharmacology Institute Self-Assessment Program 2025

Dates: April 1, 2025 – April 1, 2028

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2025 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

  • Psychopharmacology Institute Self-Assessment Program 2024

Dates: April 1, 2024 – April 1, 2027

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2024 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

Vous vous sentez perdu au début de votre résidence en psychiatrie ?

Accédez à TOUS nos produits GRATUITEMENT pendant 3 mois !